HighLight Capital (HLC) is a private investment firm dedicated to creating long-term values through promoting technology innovations. Empowered by our deep knowledge in chemical, biological and material sciences, and leveraging our proprietary industry research and comprehensive enablement services, we strive to invest in companies that boost manufacturing efficiency and improve human wellness. HLC currently manages over US$3.8 billion, with operations across in key financial hubs, such as Tokyo, Shanghai, Hong Kong and Boston.